Cargando…

A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia

BACKGROUND: 14-3-3η (eta) is a novel serum/plasma protein biomarker involved in the upregulation of inflammatory and joint damage factors. We analysed the association of 14-3-3η with the development of clinically apparent arthritis in a cohort of subjects with arthralgia and positivity for at least...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Beers-Tas, Marian H., Marotta, Anthony, Boers, Maarten, Maksymowych, Walter P., van Schaardenburg, Dirkjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818496/ https://www.ncbi.nlm.nih.gov/pubmed/27037016 http://dx.doi.org/10.1186/s13075-016-0975-4

Ejemplares similares

The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study
por: van Beers-Tas, Marian H., et al.
Publicado: (2018)

Depressive mood and low social support are not associated with arthritis development in patients with seropositive arthralgia, although they predict increased musculoskeletal symptoms
por: Holla, Jasmijn F M, et al.
Publicado: (2018)

Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
por: Ursum, Jennie, et al.
Publicado: (2009)

14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage
por: Maksymowych, Walter P, et al.
Publicado: (2014)

Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients
por: Lübbers, Joyce, et al.
Publicado: (2016)

MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF
por: Boeters, Debbie M., et al.
Publicado: (2016)

The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study
por: van de Stadt, Lotte A, et al.
Publicado: (2010)

An ultrasound negative for subclinical synovitis in arthralgia patients: is it helpful in identifying those not developing arthritis?: A longitudinal study in four arthralgia cohorts
por: Rogier, Cleo, et al.
Publicado: (2022)

Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia
por: ten Brinck, R. M., et al.
Publicado: (2018)

Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages
por: Trimova, Gulzhan, et al.
Publicado: (2020)

Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis
por: Carrier, Nathalie, et al.
Publicado: (2016)

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
por: van Boheemen, Laurette, et al.
Publicado: (2021)

Prevalence and relevant factors of positive RF in brucellosis patients with arthralgia
por: Zhang, Siwen, et al.
Publicado: (2021)

Subclinical synovitis in arthralgia: how often does it result in clinical arthritis? Reflecting on starting points for disease-modifying anti-rheumatic drug treatment
por: Rogier, Cleo, et al.
Publicado: (2020)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

14-3-3η Promotes Invadosome Formation via the FOXO3–Snail Axis in Rheumatoid Arthritis Fibroblast-like Synoviocytes
por: Kadiri, Maleck, et al.
Publicado: (2021)

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab
por: Hirata, Shintaro, et al.
Publicado: (2015)

ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese
por: Terao, Chikashi, et al.
Publicado: (2012)

CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis
por: Paulissen, Sandra M. J., et al.
Publicado: (2015)

Expression of Prostaglandin E(2) Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients
por: de Hair, Maria J. H., et al.
Publicado: (2015)

The Role of 14-3-3 η as a Biomarker in Rheumatoid Arthritis
por: Abdelhafiz, Dima, et al.
Publicado: (2021)

ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation
por: Verstappen, Marloes, et al.
Publicado: (2022)

An unfavorable body composition is common in early arthritis patients: A case control study
por: Turk, Samina A., et al.
Publicado: (2018)

Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis
por: Reyhan, Iris, et al.
Publicado: (2021)

Response to the ACPA's critique.
por: Repetto, R, et al.
Publicado: (1998)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
por: Boeters, Debbie M., et al.
Publicado: (2017)

The Infectious Basis of ACPA-Positive Rheumatoid Arthritis
por: Sakkas, Lazaros I., et al.
Publicado: (2017)

Gastrodin Protects Cardiomyocytes from Anoxia/Reoxygenation Injury by 14-3-3η
por: Zhu, Meifang, et al.
Publicado: (2018)

14-3-3η Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
por: Dalrymple, Austin, et al.
Publicado: (2021)

Autoantikörper und die autoreaktive Immunantwort: ACPA sind mehr als nur ACPA
por: Scherer, H. U.
Publicado: (2020)

Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis
por: van Beers-Tas, Marian, et al.
Publicado: (2020)

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA
por: Suwannalai, Parawee, et al.
Publicado: (2011)

Smartphone‐Assisted Patient‐Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled Trial
por: Seppen, Bart, et al.
Publicado: (2022)

A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis
por: Padyukov, Leonid, et al.
Publicado: (2010)

Diagnostic accuracy of 14‐3‐3 η protein in rheumatoid arthritis: A meta‐analysis
por: Wang, Decai, et al.
Publicado: (2020)

14-3-3η protein is associated with disease activity and osteoporosis in patients with rheumatoid arthritis
por: Adel, Yasmin, et al.
Publicado: (2022)

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
por: Cunningham, Kevin Y., et al.
Publicado: (2023)

Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial
por: van Eijk, Izhar C., et al.
Publicado: (2012)

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial
por: Seegobin, Seth D, et al.
Publicado: (2014)

High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis
por: Gomez-Cabrero, David, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lsdbvhabnphpkkk12hpmcch5dd